Human protease nexin-I. Further characterization using a highly specific polyclonal antibody.
We have used purified protease nexin-I (PN-I) from human fibroblasts to develop a polyclonal antibody that specifically blocks the PN-I-mediated cellular binding of thrombin and urokinase. Anti-PN-I IgG did not inhibit the binding of 125I-epidermal growth factor-binding protein to fibroblasts, which is mediated by protease nexin-II, another cell-secreted, serine protease inhibitor that is distinct from PN-I. This furthers the belief that the protease nexins are distinct from one another. In addition, while anti-PN-I IgG immunoprecipitated PN-I X thrombin complexes, it did not do so with antithrombin-III X thrombin. Metabolically labeled PN-I was also immunoprecipitated by IgG, indicating that the protein can be labeled in vivo. The antibody also recognized primarily one band on Western transfers of conditioned medium from fibroblast cultures. These results suggest that anti-PN-I will be useful in probing the physiological role of PN-I as well as its biosynthesis.
D016564:Amyloid beta-Protein Precursor; D000818:Animals; D000906:Antibodies; D001667:Binding, Competitive; D002352:Carrier Proteins / Q000276:immunology / Q000378:metabolism*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G; D058255:Protease Nexins; D011817:Rabbits; D011956:Receptors, Cell Surface; D013917:Thrombin / Q000378:metabolism
D016564:Amyloid beta-Protein Precursor; D000906:Antibodies; D002352:Carrier Proteins; D007074:Immunoglobulin G; D058255:Protease Nexins; D011956:Receptors, Cell Surface; D013917:Thrombin